FDA approves first medical device using rutgers biomaterial
Rutgers scientists and TyRx Pharma, Inc., have announced the Food and Drug Administration's clearance of a new medical device for hernia repair that incorporates a biodegradable technology developed at the university. This action signals a paradigm shift in the application of biomaterials from permanent prosthetic replacements toward regenerative medicine, in which materials help the body to repa...Finding the right mix: A biomaterial blend library
From dental implants to hip replacements, biomaterials have become big business. But scientists pursuing this modern medical revolution share a basic challenge: biocompatibility. How will a biomaterial on the lab bench actually work inside the human body? Will a patient accept the new material or suffer an inflammatory response? And can that material survive in a human's complex system? T...GORE MYCROMESH® PLUS Biomaterial
Description:GORE MYCROMESH® PLUS Biomaterial is the first hernia repair material with antimicrobial technology for controlling potential operative contamination of the material. This advanced ePTFE biomaterial contains two antimicrobial preservative agents, silver carbonate and chlorhexidine diacetate, which act to inhibit bacterial colonization on the patch for up to 10 days post-implantation. It also o...GORE DUALMESH PLUS Biomaterial
Description:GORE DUALMESH PLUS Biomaterial is the first dual-surface hernia repair material with antimicrobial technology for controlling potential operative contamination of the material. This advanced ePTFE biomaterial contains two antimicrobial preservative agents, silver carbonate and chlorhexidine diacetate, which act to inhibit bacterial colonization on the patch for up to 10 days post-implantation....